البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
IPRATROPIUM BROMIDE
BOEHRINGER INGELHEIM ISRAEL LTD.
R03BB01
RESPIRATOR SOLUTION
IPRATROPIUM BROMIDE 0.25 MG/ML
INHALATION
Required
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG
IPRATROPIUM BROMIDE
For the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema . Aerovent respirator solution is of particular benefit in relieving acute bronchospasm when used concomitantly with inhaled beta agonists.
2022-01-31
Aerovent Proposed patient information Boehringer Ingelheim January 2022 PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS (PREPARATIONS) - 1986 This medicine is dispensed with a doctor’s prescription only AEROVENT ® RESPIRATOR SOLUTION EVERY 1 ML (20 DROPS) CONTAINS: IPRATROPIUM BROMIDE 0.25 MG Inactive ingredients and allergens: see section 2 under ‘Important information about some of this medicine’s ingredients’, and section 6 ‘Additional information'. READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. This leaflet contains concise information about this medicine. If you have any further questions, consult your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if it seems to you that their medical condition is similar to yours. 1. WHAT IS THIS MEDICINE INTENDED FOR? Relieving symptoms of reversible bronchospasm associated with asthma, chronic bronchitis, and emphysema. AEROVENT is particularly effective in relieving acute bronchial constriction when given together with inhaled beta agonists. THERAPEUTIC GROUP: anticholinergic. 2. BEFORE USING THIS MEDICINE DO NOT USE THIS MEDICINE IF: • You are sensitive (allergic) to the active ingredient ipratropium bromide, to atropine or atropine derivatives (anticholinergic active substances with similar structure) or to any of the other ingredients in this medicine (listed in section 6). SPECIAL WARNINGS ABOUT USING THIS MEDICINE Consult your doctor or pharmacist before using this medicine. TALK TO YOUR DOCTOR BEFORE TREATMENT WITH AEROVENT IF: • Care must be taken to ensure that the solution or the mist from the nebulizer does not get into the eyes. AEROVENT should be used with special care in patients with a tendency to narrow-angle glaucoma. If the medicine accidentally gets in your eyes while you are using it, slight and reversible eye complications can occur. In patients with elevated intraocular pressure (narrow angle glaucoma) particularly, there is اقرأ الوثيقة كاملة
Aerovent Proposed prescribing information Boehringer Ingelheim January 2022- Minor Update AEROVENT IPRATROPIUM BROMIDE 0.25 MG/ML Respirator solution 1. NAME OF THE MEDICINAL PRODUCT AEROVENT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml (20 drops) contains: Ipratropium bromide 0.25 mg Excipient with known effect: 0.10 mg benzalkonium chloride/ml see section 4.4. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM RESPIRATOR SOLUTION 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema. Aerovent respirator solution is of particular benefit in relieving acute bronchospasm when used concomitantly with inhaled beta agonists. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The dosage should be adapted to the individual requirements of the patient; patients should also be kept under medical supervision during treatment. It is advisable not to greatly exceed the recommended daily dose during both acute and maintenance treatment. If therapy does not produce a significant improvement or if the patient's condition worsens, medical advice must be sought in order to determine a new regimen of therapy. In the case of acute or rapidly worsening dyspnea, a doctor should be consulted immediately. Note: Aerovent and disodium cromoglycate inhalation solutions should not be simultaneously administered in the same nebulizer as precipitation may occur. Aerovent Respirator Solution may be administered from an intermittent positive pressure ventilator or from suitable nebulizers. Aerovent Proposed prescribing information Boehringer Ingelheim January 2022- Minor Update The following dosages are recommended: ADULTS 0.1 - 0.5 mg (0.4 - 2.0 ml = 8-40 drops) up to 4 times daily. CHILDREN _6-12 Years_ : 0.25 mg (20 drops, i.e., 1 ml) 3 to 4 times daily. _Children < 6 years of age:_ As only limited information is available for this age group, the following dose schedule should only be given under regular medical اقرأ الوثيقة كاملة